Accendra Health Inc (ACH)

Currency in USD
1.40
-1.40(-50.00%)
Closed·
1.34-0.06(-4.29%)
·
Advertisement
Unusual trading volume
Trading near 52-week Low
ACH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.241.74
52 wk Range
1.245.85
Key Statistics
Prev. Close
2.8
Open
1.74
Day's Range
1.24-1.74
52 wk Range
1.24-5.85
Volume
8.09M
Average Volume (3m)
891.5K
1-Year Change
-69.7624%
Book Value / Share
-6.08
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ACH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.39
Upside
+213.57%
Members' Sentiments
Bearish
Bullish
ProTips
Management has been aggressively buying back shares

Accendra Health Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

2 Buy
2 Hold
2 Sell
Ratings:
6 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 4.39
(+213.57% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
UBS
Hold4.00+185.71%7.00Downgrade03/11/2025
Leerink Partners
Hold6.00+328.57%5.00Maintain08/10/2025
JPMorgan
Sell6.00+328.57%7.00Maintain27/08/2025
UBS
Buy7.00+400.00%13.00Maintain13/08/2025
Baird
Buy7.00+400.00%10.00Maintain12/08/2025

Accendra Health Inc SWOT Analysis


Strategic Expansion
Explore Owens & Minor's $1.36 billion acquisition of Rotech, aimed at strengthening its position in the high-growth Patient Direct business
Financial Challenges
Delve into the company's mixed Q3 results, revised guidance, and the implications of its recent CFO transition on financial stability
Market Dynamics
Learn how Owens & Minor navigates industry shifts, including the impact of GLP-1 drugs and potential benefits from Chinese tariffs
Analyst Perspectives
Discover varied analyst views on OMI's future, with price targets ranging from $14 to $23, reflecting both optimism and caution
Read full SWOT analysis

Accendra Health Inc Earnings Call Summary for Q2/2026

  • Accendra Health slashed 2026 guidance to $2.45B-$2.55B revenue and $300M-$320M adjusted EBITDA; shares plunged 34% to $1.86 in premarket.
  • Q2 adjusted EBITDA hit $60.1M, with collections delays from intense payer audits reducing revenue and EBITDA by approximately $10M in the quarter.
  • Sleep revenue grew 5.5% and diabetes 4% YoY, but respiratory, wound care, and CGM categories remained weak; overall growth just 2% ex-payer impact.
  • Company expects Q4 to strengthen significantly, targeting normalized $100M annual free cash flow in 2027 after new partnerships launch and costs stabilize.
  • CEO Ed Pesicka plans to retire by end-2026; firm reduced debt by $400M since March but faces cash flow pressure and ongoing payer audit challenges.
Last Updated: 10/08/2026, 13:58
Read Full Transcript

Earnings

Latest Release
10/08/2026
EPS / Forecast
-0.19 / 0.12
Revenue / Forecast
613.2M / 632.21M
EPS Revisions
Last 90 days

Compare ACH to Peers and Sector

Metrics to compare
ACH
Peers
Sector
Relationship
P/E Ratio
−1.0x−4.9x−0.4x
PEG Ratio
0.01−0.110.00
Price/Book
−0.2x2.4x2.6x
Price / LTM Sales
0.0x1.1x3.1x
Upside (Analyst Target)
60.7%36.0%48.2%
Fair Value Upside
Unlock24.3%5.8%Unlock

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
23.53M30.73%65.89M
Other Institutional Investors
52.85M69.01%147.98M
Public Companies & Retail Investors
199.19K0.26%557.72K
Total
76.58M100.00%214.43M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Coliseum Capital Management, LLC17.11%13,100,80736,682
Coliseum Capital Partners LP13.92%10,657,33729,841

People Also Watch

2.29
AVD
-4.98%
96.78
AGL
+1.33%
4.11
GEMI
+0.49%
2.130
SCKT
+451.70%
6.57
DBI
+0.31%

FAQ

What Is the Accendra Health (NYSE: ACH) Share Price Today?

The Accendra Health stock price today is 1.40 USD.

What Stock Exchange Does Accendra Health (ACH) Trade On?

Accendra Health is listed and trades on the New York Stock Exchange.

What Is the Ticker (Stock Symbol) for Accendra Health?

The stock symbol (also called a 'ticker') for Accendra Health is "ACH."

What Is the Current Accendra Health Market Capitalisation?

As of today, Accendra Health (NYSE: ACH) market cap is 107.22M USD.

What Is Accendra Health's (ACH) Earnings Per Share (TTM)?

The Accendra Health EPS is currently -1.37 (Trailing Twelve Months).

When Is the Next Accendra Health Earnings Date?

Accendra Health's next earnings report will be released on 04/11/2026.

Is ACH a Buy or Sell From a Technical Analyst Perspective?

Based on today's Accendra Health moving averages and other technical indicators, the daily buy/sell signal for ACH stock is Strong Sell.

How Many Times Has Accendra Health Stock Split?

Accendra Health has split 4 times. (See the ACH stock split history page for full effective split date and price information.)

How Many Employees Does Accendra Health Have?

Accendra Health has 6500 employees, based on their latest Companies House report.

What is the current trading status of Accendra Health (NYSE: ACH)?

As of 11/08/2026, Accendra Health (ACH) is trading at a share price of 1.40 USD, with a previous close of 2.80 USD. The stock has fluctuated within a day range of 1.24 USD to 1.74 USD, while its 52-week range spans from 1.24 USD to 5.85 USD.

What Is Accendra Health (ACH) Price Target According to Analysts?

The average 12-month price target for Accendra Health is 4.39 USD, with a high estimate of 6 USD and a low estimate of 2.7 USD. 2 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an +213.57% Upside potential.

What Is the ACH Premarket Price?

ACH's last pre-market stock price is 1.70 USD. The pre-market share volume is 196,540.00, and the stock has decreased by -1.10, or -39.29%.

What Is the ACH After Hours Price?

ACH's last after hours stock price is 1.34 USD, the stock has decreased by -0.06, or -4.29%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.